133 related articles for article (PubMed ID: 37246888)
1. Establishment of Zebrafish Patient-derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing.
Usai A; Di Franco G; Gabellini C; Morelli L; Raffa V
J Vis Exp; 2023 May; (195):. PubMed ID: 37246888
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.
Gaudenzi G; Albertelli M; Dicitore A; Würth R; Gatto F; Barbieri F; Cotelli F; Florio T; Ferone D; Persani L; Vitale G
Endocrine; 2017 Aug; 57(2):214-219. PubMed ID: 27481363
[TBL] [Abstract][Full Text] [Related]
3. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine.
Di Franco G; Usai A; Funel N; Palmeri M; Montesanti IER; Bianchini M; Gianardi D; Furbetta N; Guadagni S; Vasile E; Falcone A; Pollina LE; Raffa V; Morelli L
World J Gastroenterol; 2020 Jun; 26(21):2792-2809. PubMed ID: 32550755
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish Xenograft Model to Study Human Cancer.
Somasagara RR; Leung T
Methods Mol Biol; 2022; 2413():45-53. PubMed ID: 35044653
[TBL] [Abstract][Full Text] [Related]
5. Zebrafish Patient-Derived Xenograft Model to Predict Treatment Outcomes of Colorectal Cancer Patients.
Di Franco G; Usai A; Piccardi M; Cateni P; Palmeri M; Pollina LE; Gaeta R; Marmorino F; Cremolini C; Dente L; Massolo A; Raffa V; Morelli L
Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884780
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Pancreatobiliary Cancer Zebrafish Avatars for Chemotherapy Screening.
Tavares Barroso M; Costa B; Rebelo de Almeida C; Castillo Martin M; Couto N; Carvalho T; Fior R
Cells; 2021 Aug; 10(8):. PubMed ID: 34440847
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Sensitivity and Efficacy of Clinical Chemotherapy Using Larval Zebrafish Patient-Derived Xenografts of Gastric Cancer.
Zhai J; Wu J; Wang Y; Fan R; Xie G; Wu F; He Y; Qian S; Tan A; Yao X; He M; Shen L
Front Cell Dev Biol; 2021; 9():680491. PubMed ID: 34164399
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish Avatar to Develop Precision Breast Cancer Therapies.
Corsinovi D; Usai A; Sarlo M; Giannaccini M; Ori M
Anticancer Agents Med Chem; 2022; 22(4):748-759. PubMed ID: 33797388
[TBL] [Abstract][Full Text] [Related]
10. Modeling oncolytic virus dynamics in the tumor microenvironment using zebrafish.
Mealiea D; Boudreau E; De Silva N; Okamoto L; Ho T; Fish JE; McCart JA
Cancer Gene Ther; 2021 Aug; 28(7-8):769-784. PubMed ID: 32647136
[TBL] [Abstract][Full Text] [Related]
11. Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis.
Martinez-Lopez M; Póvoa V; Fior R
J Vis Exp; 2021 Jun; (172):. PubMed ID: 34223839
[TBL] [Abstract][Full Text] [Related]
12. The Zebrafish Xenograft Platform: Evolution of a Novel Cancer Model and Preclinical Screening Tool.
Wertman J; Veinotte CJ; Dellaire G; Berman JN
Adv Exp Med Biol; 2016; 916():289-314. PubMed ID: 27165359
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish Xenograft Model for Studying Pancreatic Cancer-Instructed Innate Immune Microenvironment.
Wang X; Li W; Jiang H; Ma C; Huang M; Wei X; Wang W; Jing L
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742884
[TBL] [Abstract][Full Text] [Related]
14. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
15. Modeling of Solid-Tumor Microenvironment in Zebrafish (Danio Rerio) Larvae.
Yao Y; Wang L; Wang X
Adv Exp Med Biol; 2020; 1219():413-428. PubMed ID: 32130712
[TBL] [Abstract][Full Text] [Related]
16. A Model of a Zebrafish Avatar for Co-Clinical Trials.
Usai A; Di Franco G; Colucci P; Pollina LE; Vasile E; Funel N; Palmeri M; Dente L; Falcone A; Morelli L; Raffa V
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183229
[TBL] [Abstract][Full Text] [Related]
17. A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer.
Maradonna F; Fontana CM; Sella F; Giommi C; Facchinello N; Rampazzo C; Caichiolo M; Hoseinifar SH; Dalla Valle L; Van Doan H; Carnevali O
Cell Death Dis; 2022 Dec; 13(12):1069. PubMed ID: 36564370
[TBL] [Abstract][Full Text] [Related]
18. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts.
Almstedt E; Rosén E; Gloger M; Stockgard R; Hekmati N; Koltowska K; Krona C; Nelander S
Neuro Oncol; 2022 May; 24(5):726-738. PubMed ID: 34919147
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model.
Gatzweiler C; Ridinger J; Ayhan S; Najafi S; Peterziel H; Witt O; Oehme I
Methods Mol Biol; 2023; 2589():75-85. PubMed ID: 36255618
[TBL] [Abstract][Full Text] [Related]
20. Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma.
Magouliotis DE; Lafazanis K; Koutsougianni F; Sakellaridis N; Ioannou M; Zacharoulis D; Dimas K
In Vivo; 2022; 36(3):1114-1119. PubMed ID: 35478141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
